These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
463 related items for PubMed ID: 10209563
1. The IGF-I response to very low rhGH doses is preserved in human ageing. Arvat E, Ceda G, Ramunni J, Lanfranco F, Aimaretti G, Gianotti L, Broglio F, Ghigo E. Clin Endocrinol (Oxf); 1998 Dec; 49(6):757-63. PubMed ID: 10209563 [Abstract] [Full Text] [Related]
2. Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Maccario M, Tassone F, Gauna C, Oleandri SE, Aimaretti G, Procopio M, Grottoli S, Pflaum CD, Strasburger CJ, Ghigo E. Eur J Endocrinol; 2001 Mar; 144(3):251-6. PubMed ID: 11248744 [Abstract] [Full Text] [Related]
3. Enhancement of the peripheral sensitivity to growth hormone in adults with GH deficiency. Aimaretti G, Fanciulli G, Bellone S, Maccario M, Arvat E, Delitala G, Camanni F, Ghigo E. Eur J Endocrinol; 2001 Sep; 145(3):267-72. PubMed ID: 11517006 [Abstract] [Full Text] [Related]
4. Normal IGF-I and enhanced IGFBP-3 response to very low rhGH dose in patients with dilated cardiomyopathy. Broglio F, Benso A, Arvat E, Aimaretti G, Gottero C, Granata R, Boghen MF, Bobbio M, Camanni F, Ghigo E. J Endocrinol Invest; 2000 Sep; 23(8):520-5. PubMed ID: 11021768 [Abstract] [Full Text] [Related]
5. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Broglio F, Fubini A, Morello M, Arvat E, Aimaretti G, Gianotti L, Boghen MF, Deghenghi R, Mangiardi L, Ghigo E. Clin Endocrinol (Oxf); 1999 Apr; 50(4):417-30. PubMed ID: 10468900 [Abstract] [Full Text] [Related]
6. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders. Maghnie M, Barreca A, Ventura M, Tinelli C, Ponzani P, De Giacomo C, Maggiore G, Severi F. Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564 [Abstract] [Full Text] [Related]
7. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults. Aimaretti G, Colao A, Corneli G, Pivonello R, MacCario M, Morrison K, Pflaum CD, Strasburger CJ, Lombardi G, Ghigo E. Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983 [Abstract] [Full Text] [Related]
11. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment. Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E. Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423 [Abstract] [Full Text] [Related]
12. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men. Gentili A, Mulligan T, Godschalk M, Clore J, Patrie J, Iranmanesh A, Veldhuis JD. J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328 [Abstract] [Full Text] [Related]
13. 17beta-estradiol regulation of human growth hormone (hGH), insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) axis in hypoestrogenic, hypergonadotropic women. Milewicz T, Krzysiek J, Sztefko K, Radowicki S, Krzyczkowska-Sendrakowska M. Endokrynol Pol; 2005 Feb; 56(6):876-82. PubMed ID: 16821205 [Abstract] [Full Text] [Related]
14. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature. Cotterill AM, Camacho-Hübner C, Duquesnoy P, Savage MO. Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560 [Abstract] [Full Text] [Related]
15. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults. Giannoulis MG, Boroujerdi MA, Powrie J, Dall R, Napoli R, Ehrnborg C, Pentecost C, Cittadini A, Jørgensen JO, Sonksen PH, GH-2000 Study Group. Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413 [Abstract] [Full Text] [Related]
16. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone. Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS. Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221 [Abstract] [Full Text] [Related]
17. Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human aging. Ghigo E, Arvat E, Gianotti L, Grottoli S, Rizzi G, Ceda GP, Boghen MF, Deghenghi R, Camanni F. Eur J Endocrinol; 1996 Oct; 135(4):407-12. PubMed ID: 8921821 [Abstract] [Full Text] [Related]
18. Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Ghigo E, Aimaretti G, Maccario M, Fanciulli G, Arvat E, Minuto F, Giordano G, Delitala G, Camanni F. Am J Physiol; 1999 Jun; 276(6):E1009-13. PubMed ID: 10362612 [Abstract] [Full Text] [Related]
19. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR, Marcus R. J Clin Endocrinol Metab; 1994 Nov; 79(5):1361-6. PubMed ID: 7525633 [Abstract] [Full Text] [Related]
20. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. Khorram O, Laughlin GA, Yen SS. J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536 [Abstract] [Full Text] [Related] Page: [Next] [New Search]